Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
Clinical Trial ID NCT01189643
PubWeight™ 2.39‹?›
🔗 Visit the ClinicalTrials.gov page for NCT01189643
Top papers
| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
Next 100